{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:04:22Z","timestamp":1789574662589,"version":"build-2803163510"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302918"],"award-info":[{"award-number":["82302918"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273020"],"award-info":[{"award-number":["82273020"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ24H160044"],"award-info":[{"award-number":["LQ24H160044"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY23H160024"],"award-info":[{"award-number":["LY23H160024"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["QN26H160024"],"award-info":[{"award-number":["QN26H160024"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017531","name":"Medical and Health Research Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2024KY758"],"award-info":[{"award-number":["2024KY758"]}],"id":[{"id":"10.13039\/501100017531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017531","name":"Medical and Health Research Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2024KY1405"],"award-info":[{"award-number":["2024KY1405"]}],"id":[{"id":"10.13039\/501100017531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017531","name":"Medical and Health Research Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2025HY0770"],"award-info":[{"award-number":["2025HY0770"]}],"id":[{"id":"10.13039\/501100017531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017531","name":"Medical and Health Research Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2025HY0772"],"award-info":[{"award-number":["2025HY0772"]}],"id":[{"id":"10.13039\/501100017531","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Seed Foundation of Zhejiang Provincial People\u2019s Hospital","award":["ZRY2022J007"],"award-info":[{"award-number":["ZRY2022J007"]}]},{"name":"Hangzhou Biomedical and Health Industry Development Support Science and Technology Special","award":["2024WJC072"],"award-info":[{"award-number":["2024WJC072"]}]},{"name":"Hangzhou Biomedical and Health Industry Development Support Science and Technology Special","award":["2024WJC187"],"award-info":[{"award-number":["2024WJC187"]}]},{"name":"Hangzhou Biomedical and Health Industry Development Support Science and Technology Special","award":["2022WJC232"],"award-info":[{"award-number":["2022WJC232"]}]},{"name":"Hangzhou Biomedical and Health Industry Development Support Science and Technology Special","award":["2023WJC023"],"award-info":[{"award-number":["2023WJC023"]}]},{"name":"Zhejiang Province Traditional Chinese Medicine Science and Technology Project","award":["2026ZL0638"],"award-info":[{"award-number":["2026ZL0638"]}]},{"name":"Hangzhou Joint Fund of Zhejiang Provincial Natural Science Foundation of China","award":["LHZQN26H160006"],"award-info":[{"award-number":["LHZQN26H160006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07764-4","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:05:36Z","timestamp":1777457136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["MTHFD2: a promising metabolic checkpoint for diseases"],"prefix":"10.1186","volume":"24","author":[{"given":"Xiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renhao","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8376-3690","authenticated-orcid":false,"given":"Xinxin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"6670","key":"7764_CR1","doi-asserted-by":"publisher","first-page":"eabp9201","DOI":"10.1126\/science.abp9201","volume":"382","author":"VN Pham","year":"2023","unstructured":"Pham VN, Bruemmer KJ, Toh JDW, Ge EJ, Tenney L, Ward CC, et al. Formaldehyde regulates S-adenosylmethionine biosynthesis and one-carbon metabolism. Science. 2023;382(6670):eabp9201.","journal-title":"Science"},{"issue":"10","key":"7764_CR2","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1016\/j.cmet.2024.07.021","volume":"36","author":"EW Lim","year":"2024","unstructured":"Lim EW, Fallon RJ, Bates C, Ideguchi Y, Nagasaki T, Handzlik MK, et al. Serine and Glycine physiology reversibly modulate retinal and peripheral nerve function. Cell Metab. 2024;36(10):2315\u201328. e6.","journal-title":"Cell Metab"},{"issue":"12","key":"7764_CR3","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1158\/2159-8290.CD-23-1059","volume":"13","author":"MC Lin","year":"2023","unstructured":"Lin MC, Moller SH, Ho PC. Re-Formate T-cell antitumor responses. Cancer Discov. 2023;13(12):2507\u20139.","journal-title":"Cancer Discov"},{"issue":"1","key":"7764_CR4","doi-asserted-by":"publisher","first-page":"e1521","DOI":"10.1002\/ctm2.1521","volume":"14","author":"X Ren","year":"2024","unstructured":"Ren X, Wang X, Zheng G, Wang S, Wang Q, Yuan M, et al. Targeting one-carbon metabolism for cancer immunotherapy. Clin Transl Med. 2024;14(1):e1521.","journal-title":"Clin Transl Med"},{"issue":"2","key":"7764_CR5","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.cmet.2024.10.017","volume":"37","author":"K Lin","year":"2025","unstructured":"Lin K, Wei L, Wang R, Li L, Song S, Wang F, et al. Disrupted methionine cycle triggers muscle atrophy in cancer cachexia through epigenetic regulation of REDD1. Cell Metab. 2025;37(2):460\u201376. e8.","journal-title":"Cell Metab"},{"issue":"1","key":"7764_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1158\/0008-5472.CAN-23-1290","volume":"84","author":"L Ramos","year":"2024","unstructured":"Ramos L, Henriksson M, Helleday T, Green AC. Targeting MTHFD2 to exploit Cancer-Specific metabolism and the DNA damage response. Cancer Res. 2024;84(1):9\u201316.","journal-title":"Cancer Res"},{"key":"7764_CR7","doi-asserted-by":"crossref","unstructured":"Cuthbertson CR, Arabzada Z, Bankhead A 3rd, Kyani A, Neamati N. A review of Small-Molecule inhibitors of One-Carbon enzymes: SHMT2 and MTHFD2 in the spotlight. ACS Pharmacol Transl Sci. 2021;4(2):624\u201346.","DOI":"10.1021\/acsptsci.0c00223"},{"issue":"1","key":"7764_CR8","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41420-024-02006-2","volume":"10","author":"R Su","year":"2024","unstructured":"Su R, Shao Y, Huang M, Liu D, Yu H, Qiu Y. Immunometabolism in cancer: basic mechanisms and new targeting strategy. Cell Death Discov. 2024;10(1):236.","journal-title":"Cell Death Discov"},{"issue":"13","key":"7764_CR9","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1038\/s41388-021-01695-8","volume":"40","author":"LN Zhao","year":"2021","unstructured":"Zhao LN, Bjorklund M, Caldez MJ, Zheng J, Kaldis P. Therapeutic targeting of the mitochondrial one-carbon pathway: perspectives, pitfalls, and potential. Oncogene. 2021;40(13):2339\u201354.","journal-title":"Oncogene"},{"issue":"3","key":"7764_CR10","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.drudis.2020.12.006","volume":"26","author":"C Yang","year":"2021","unstructured":"Yang C, Zhang J, Liao M, Yang Y, Wang Y, Yuan Y, et al. Folate-mediated one-carbon metabolism: a targeting strategy in cancer therapy. Drug Discov Today. 2021;26(3):817\u201325.","journal-title":"Drug Discov Today"},{"issue":"27","key":"7764_CR11","doi-asserted-by":"publisher","first-page":"14616","DOI":"10.1016\/S0021-9258(17)38612-X","volume":"260","author":"NR Mejia","year":"1985","unstructured":"Mejia NR, MacKenzie RE. NAD-dependent methylenetetrahydrofolate dehydrogenase is expressed by immortal cells. J Biol Chem. 1985;260(27):14616\u201320.","journal-title":"J Biol Chem"},{"key":"7764_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40170-017-0173-0","volume":"5","author":"M Shin","year":"2017","unstructured":"Shin M, Momb J, Appling DR. Human mitochondrial MTHFD2 is a dual redox cofactor-specific methylenetetrahydrofolate dehydrogenase\/methenyltetrahydrofolate cyclohydrolase. Cancer Metab. 2017;5:11.","journal-title":"Cancer Metab"},{"key":"7764_CR13","doi-asserted-by":"publisher","first-page":"15029","DOI":"10.1038\/srep15029","volume":"5","author":"N Gustafsson Sheppard","year":"2015","unstructured":"Gustafsson Sheppard N, Jarl L, Mahadessian D, Strittmatter L, Schmidt A, Madhusudan N, et al. The folate-coupled enzyme MTHFD2 is a nuclear protein and promotes cell proliferation. Sci Rep. 2015;5:15029.","journal-title":"Sci Rep"},{"key":"7764_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40170-018-0185-4","volume":"6","author":"C Koufaris","year":"2018","unstructured":"Koufaris C, Nilsson R. Protein interaction and functional data indicate MTHFD2 involvement in RNA processing and translation. Cancer Metab. 2018;6:12.","journal-title":"Cancer Metab"},{"key":"7764_CR15","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1038\/ncomms4128","volume":"5","author":"R Nilsson","year":"2014","unstructured":"Nilsson R, Jain M, Madhusudhan N, Sheppard NG, Strittmatter L, Kampf C, et al. Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer. Nat Commun. 2014;5:3128.","journal-title":"Nat Commun"},{"key":"7764_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bbrc.2023.06.074","volume":"674","author":"Y Wang","year":"2023","unstructured":"Wang Y, Hongu T, Nishimura T, Takeuchi Y, Takano H, Daikoku T, et al. Mitochondrial one-carbon metabolic enzyme MTHFD2 facilitates mammary gland development during pregnancy. Biochem Biophys Res Commun. 2023;674:183\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"7764_CR17","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1128\/MCB.22.12.4158-4166.2002","volume":"22","author":"E Di Pietro","year":"2002","unstructured":"Di Pietro E, Sirois J, Tremblay ML, MacKenzie RE. Mitochondrial NAD-dependent methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase is essential for embryonic development. Mol Cell Biol. 2002;22(12):4158\u201366.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"7764_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13059-020-01990-9","volume":"21","author":"RA Avelar","year":"2020","unstructured":"Avelar RA, Ortega JG, Tacutu R, Tyler EJ, Bennett D, Binetti P, et al. A multidimensional systems biology analysis of cellular senescence in aging and disease. Genome Biol. 2020;21(1):91.","journal-title":"Genome Biol"},{"issue":"1","key":"7764_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41598-017-18456-x","volume":"8","author":"J Koseki","year":"2018","unstructured":"Koseki J, Konno M, Asai A, Colvin H, Kawamoto K, Nishida N, et al. Enzymes of the one-carbon folate metabolism as anticancer targets predicted by survival rate analysis. Sci Rep. 2018;8(1):303.","journal-title":"Sci Rep"},{"issue":"10","key":"7764_CR20","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1158\/1541-7786.MCR-15-0117","volume":"13","author":"PM Tedeschi","year":"2015","unstructured":"Tedeschi PM, Vazquez A, Kerrigan JE, Bertino JR. Mitochondrial methylenetetrahydrofolate dehydrogenase (MTHFD2) overexpression is associated with tumor cell proliferation and is a novel target for drug development. Mol Cancer Res. 2015;13(10):1361\u20136.","journal-title":"Mol Cancer Res"},{"key":"7764_CR21","first-page":"28","volume":"118","author":"G Li","year":"2021","unstructured":"Li G, Wu J, Li L, Jiang P. p53 deficiency induces MTHFD2 transcription to promote cell proliferation and restrain DNA damage. Proc Natl Acad Sci U S A. 2021;118:28.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7764_CR22","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3389\/fonc.2020.00658","volume":"10","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, Leung GKK. More than a metabolic enzyme: MTHFD2 as a novel target for anticancer therapy? Front Oncol. 2020;10:658.","journal-title":"Front Oncol"},{"key":"7764_CR23","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.2147\/COPD.S325328","volume":"16","author":"H Yu","year":"2021","unstructured":"Yu H, Guo W, Liu Y, Wang Y. Immune characteristics analysis and transcriptional regulation prediction based on gene signatures of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2021;16:3027\u201339.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"7764_CR24","doi-asserted-by":"crossref","unstructured":"Liu H, Ou J, Chen Y, Chen Q, Luo M, Wang T, et al. Association of maternal folate intake and offspring MTHFD1 and MTHFD2 genes with congenital heart disease. Nutrients. 2023;15(16).","DOI":"10.3390\/nu15163502"},{"issue":"1","key":"7764_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12967-023-04241-0","volume":"21","author":"Y Qu","year":"2023","unstructured":"Qu Y, Zhai R, Wang D, Wang Z, Hou G, Wu C, et al. Mitochondrial folate pathway regulates myofibroblast differentiation and silica-induced pulmonary fibrosis. J Transl Med. 2023;21(1):365.","journal-title":"J Transl Med"},{"key":"7764_CR26","first-page":"9043300","volume":"2022","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Xia Y, Kuang G, Cao J, Shen F, Zhu M. Cross-Tissue analysis using machine learning to identify novel biomarkers for knee osteoarthritis. Comput Math Methods Med. 2022;2022:9043300.","journal-title":"Comput Math Methods Med"},{"issue":"1","key":"7764_CR27","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1038\/s41467-018-04602-0","volume":"9","author":"J Hitzel","year":"2018","unstructured":"Hitzel J, Lee E, Zhang Y, Bibli SI, Li X, Zukunft S, et al. Oxidized phospholipids regulate amino acid metabolism through MTHFD2 to facilitate nucleotide release in endothelial cells. Nat Commun. 2018;9(1):2292.","journal-title":"Nat Commun"},{"key":"7764_CR28","doi-asserted-by":"publisher","first-page":"1257107","DOI":"10.3389\/fphar.2023.1257107","volume":"14","author":"H Tang","year":"2023","unstructured":"Tang H, Hou N. Whether MTHFD2 plays a new role: from anticancer targets to anti-inflammatory disease. Front Pharmacol. 2023;14:1257107.","journal-title":"Front Pharmacol"},{"issue":"1","key":"7764_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.immuni.2021.10.011","volume":"55","author":"A Sugiura","year":"2022","unstructured":"Sugiura A, Andrejeva G, Voss K, Heintzman DR, Xu X, Madden MZ, et al. MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and function. Immunity. 2022;55(1):65\u2013e819.","journal-title":"Immunity"},{"key":"7764_CR30","doi-asserted-by":"publisher","first-page":"147047","DOI":"10.1016\/j.gene.2022.147047","volume":"852","author":"SS Cury","year":"2023","unstructured":"Cury SS, Oliveira JS, Biagi-Junior CAO, Silva WA Jr., Reis PP, Cabral-Marques O, et al. Transcriptional profiles and common genes link lung cancer with the development and severity of COVID-19. Gene. 2023;852:147047.","journal-title":"Gene"},{"issue":"3","key":"7764_CR31","doi-asserted-by":"publisher","first-page":"e0001623","DOI":"10.1128\/jvi.00016-23","volume":"97","author":"N Tang","year":"2023","unstructured":"Tang N, Chen P, Zhao C, Liu P, Tan L, Song C, et al. Newcastle disease virus manipulates mitochondrial MTHFD2-Mediated nucleotide metabolism for virus replication. J Virol. 2023;97(3):e0001623.","journal-title":"J Virol"},{"issue":"3","key":"7764_CR32","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.cmet.2019.06.003","volume":"30","author":"LW Wang","year":"2019","unstructured":"Wang LW, Shen H, Nobre L, Ersing I, Paulo JA, Trudeau S, et al. Epstein-Barr-Virus-Induced One-Carbon metabolism drives B cell transformation. Cell Metab. 2019;30(3):539\u201355. e11.","journal-title":"Cell Metab"},{"issue":"4","key":"7764_CR33","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s42255-023-00771-5","volume":"5","author":"AC Green","year":"2023","unstructured":"Green AC, Marttila P, Kiweler N, Chalkiadaki C, Wiita E, Cookson V, et al. Formate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cells. Nat Metab. 2023;5(4):642\u201359.","journal-title":"Nat Metab"},{"issue":"1","key":"7764_CR34","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3892\/etm.2021.10135","volume":"22","author":"J Huang","year":"2021","unstructured":"Huang J, Qin Y, Lin C, Huang X, Zhang F. MTHFD2 facilitates breast cancer cell proliferation via the AKT signaling pathway. Exp Ther Med. 2021;22(1):703.","journal-title":"Exp Ther Med"},{"issue":"7","key":"7764_CR35","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3727\/096504016X14829256525028","volume":"25","author":"Y Gu","year":"2017","unstructured":"Gu Y, Si J, Xiao X, Tian Y, Yang S. miR-92a inhibits proliferation and induces apoptosis by regulating methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) expression in acute myeloid leukemia. Oncol Res. 2017;25(7):1069\u201379.","journal-title":"Oncol Res"},{"issue":"35","key":"7764_CR36","doi-asserted-by":"publisher","first-page":"29516","DOI":"10.1074\/jbc.M111.335943","volume":"287","author":"SD Selcuklu","year":"2012","unstructured":"Selcuklu SD, Donoghue MT, Rehmet K, de Souza Gomes M, Fort A, Kovvuru P, et al. MicroRNA-9 Inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells. J Biol Chem. 2012;287(35):29516\u201328.","journal-title":"J Biol Chem"},{"issue":"6","key":"7764_CR37","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1111\/cbdd.14329","volume":"102","author":"GM Rather","year":"2023","unstructured":"Rather GM. Folate trapping is lethal to cancer cells. Chem Biol Drug Des. 2023;102(6):1588\u201391.","journal-title":"Chem Biol Drug Des"},{"key":"7764_CR38","doi-asserted-by":"publisher","first-page":"1098357","DOI":"10.3389\/fonc.2023.1098357","volume":"13","author":"H Zhang","year":"2023","unstructured":"Zhang H, Zhu S, Zhou H, Li R, Xia X, Xiong H. Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer. Front Oncol. 2023;13:1098357.","journal-title":"Front Oncol"},{"issue":"12","key":"7764_CR39","doi-asserted-by":"publisher","first-page":"4909","DOI":"10.1111\/cas.15159","volume":"112","author":"X Liu","year":"2021","unstructured":"Liu X, Liu S, Piao C, Zhang Z, Zhang X, Jiang Y, et al. Non-metabolic function of MTHFD2 activates CDK2 in bladder cancer. Cancer Sci. 2021;112(12):4909\u201319.","journal-title":"Cancer Sci"},{"issue":"14","key":"7764_CR40","doi-asserted-by":"publisher","first-page":"7013","DOI":"10.1111\/jcmm.16715","volume":"25","author":"Y Shi","year":"2021","unstructured":"Shi Y, Xu Y, Yao J, Yan C, Su H, Zhang X, et al. MTHFD2 promotes tumorigenesis and metastasis in lung adenocarcinoma by regulating AKT\/GSK-3beta\/beta-catenin signalling. J Cell Mol Med. 2021;25(14):7013\u201327.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"7764_CR41","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41589-024-01690-6","volume":"21","author":"J Wu","year":"2025","unstructured":"Wu J, Zhou J, Li G, Sun X, Xiang C, Chen H, et al. Metabolic determinants of germinal center B cell formation and responses. Nat Chem Biol. 2025;21(3):371\u201382.","journal-title":"Nat Chem Biol"},{"key":"7764_CR42","doi-asserted-by":"publisher","first-page":"216743","DOI":"10.1016\/j.canlet.2024.216743","volume":"588","author":"Z Wei","year":"2024","unstructured":"Wei Z, Zhang C, Song Y, Han D, Liu J, Song X, et al. CircUBE3A(2,3,4,5) promotes adenylate-uridylate-rich binding factor 1 nuclear translocation to suppress prostate cancer metastasis. Cancer Lett. 2024;588:216743.","journal-title":"Cancer Lett"},{"issue":"1","key":"7764_CR43","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13046-022-02331-3","volume":"41","author":"R Zhao","year":"2022","unstructured":"Zhao R, Feng T, Gao L, Sun F, Zhou Q, Wang X, et al. PPFIA4 promotes castration-resistant prostate cancer by enhancing mitochondrial metabolism through MTHFD2. J Exp Clin Cancer Res. 2022;41(1):125.","journal-title":"J Exp Clin Cancer Res"},{"key":"7764_CR44","doi-asserted-by":"publisher","first-page":"114412","DOI":"10.1016\/j.biopha.2023.114412","volume":"161","author":"F Zhou","year":"2023","unstructured":"Zhou F, Yuan Z, Gong Y, Li L, Wang Y, Wang X, et al. Pharmacological targeting of MTHFD2 suppresses NSCLC via the regulation of ILK signaling pathway. Biomed Pharmacother. 2023;161:114412.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"7764_CR45","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10863-024-10014-1","volume":"56","author":"X Mo","year":"2024","unstructured":"Mo X, Liu Q, Liang K, Song Y. Interference with MTHFD2 induces ferroptosis in ovarian cancer cells through ERK signaling to suppress tumor malignant progression. J Bioenerg Biomembr. 2024;56(3):333\u201345.","journal-title":"J Bioenerg Biomembr"},{"key":"7764_CR46","doi-asserted-by":"publisher","first-page":"106784","DOI":"10.1016\/j.biocel.2025.106784","volume":"185","author":"K Wang","year":"2025","unstructured":"Wang K, Yu H, Guo S, Sun G, Cao H, Xing D, et al. CAPRIN1\/TYMS\/MTHFD2 axis promotes EMT process in nasopharyngeal carcinoma development. Int J Biochem Cell Biol. 2025;185:106784.","journal-title":"Int J Biochem Cell Biol"},{"issue":"10","key":"7764_CR47","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1002\/2211-5463.13249","volume":"11","author":"Q Li","year":"2021","unstructured":"Li Q, Yang F, Shi X, Bian S, Shen F, Wu Y, et al. MTHFD2 promotes ovarian cancer growth and metastasis via activation of the STAT3 signaling pathway. FEBS Open Bio. 2021;11(10):2845\u201357.","journal-title":"FEBS Open Bio"},{"issue":"10","key":"7764_CR48","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1111\/1440-1681.13125","volume":"46","author":"Y Yan","year":"2019","unstructured":"Yan Y, Zhang D, Lei T, Zhao C, Han J, Cui J, et al. MicroRNA-33a-5p suppresses colorectal cancer cell growth by inhibiting MTHFD2. Clin Exp Pharmacol Physiol. 2019;46(10):928\u201336.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"7764_CR49","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1158\/0008-5472.CAN-21-1020","volume":"82","author":"X Ren","year":"2022","unstructured":"Ren X, Rong Z, Liu X, Gao J, Xu X, Zi Y, et al. The protein kinase activity of NME7 activates Wnt\/beta-Catenin signaling to promote One-Carbon metabolism in hepatocellular carcinoma. Cancer Res. 2022;82(1):60\u201374.","journal-title":"Cancer Res"},{"issue":"1","key":"7764_CR50","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12964-025-02289-7","volume":"23","author":"J Mo","year":"2025","unstructured":"Mo J, Zhang Y, Cao C, Zheng W, Zheng L, Wang X, et al. Activation of mechanosensitive ion channel Piezo1 linking metabolic reprogramming and pro-inflammatory responses in hepatocellular carcinoma. Cell Commun Signal. 2025;23(1):280.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"7764_CR51","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s12672-025-02355-z","volume":"16","author":"S Yao","year":"2025","unstructured":"Yao S, Elakad O, Yang XH, Altaf AR, Yu WT, Bohnenberger H, et al. MTHFD2 marks pemetrexed resistance in pulmonary adenocarcinoma with EGFR wild type. Discov Oncol. 2025;16(1):581.","journal-title":"Discov Oncol"},{"issue":"1","key":"7764_CR52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.31083\/j.fbl2901035","volume":"29","author":"J Wang","year":"2024","unstructured":"Wang J, Yu Z, Jiang Y, Le T, Wu Y, Li Z, et al. Downregulation of MTHFD2 inhibits proliferation and enhances chemosensitivity in hepatocellular carcinoma via PI3K\/AKT pathway. Front Biosci (Landmark Ed). 2024;29(1):35.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"6","key":"7764_CR53","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/jnci\/djy160","volume":"111","author":"HQ Ju","year":"2019","unstructured":"Ju HQ, Lu YX, Chen DL, Zuo ZX, Liu ZX, Wu QN, et al. Modulation of redox homeostasis by Inhibition of MTHFD2 in colorectal cancer: mechanisms and therapeutic implications. J Natl Cancer Inst. 2019;111(6):584\u201396.","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"7764_CR54","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1111\/jcmm.17863","volume":"27","author":"L Li","year":"2023","unstructured":"Li L, Zhang Y, Hu W, Zou F, Ning J, Rao T, et al. MTHFD2 promotes PD-L1 expression via activation of the JAK\/STAT signalling pathway in bladder cancer. J Cell Mol Med. 2023;27(19):2922\u201336.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"7764_CR55","first-page":"250","volume":"9","author":"T Xu","year":"2019","unstructured":"Xu T, Zhang K, Shi J, Huang B, Wang X, Qian K, et al. MicroRNA-940 inhibits glioma progression by blocking mitochondrial folate metabolism through targeting of MTHFD2. Am J Cancer Res. 2019;9(2):250\u201369.","journal-title":"Am J Cancer Res"},{"issue":"6","key":"7764_CR56","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.21037\/tlcr-20-1039","volume":"10","author":"S Yao","year":"2021","unstructured":"Yao S, Peng L, Elakad O, Kuffer S, Hinterthaner M, Danner BC, et al. One carbon metabolism in human lung cancer. Transl Lung Cancer Res. 2021;10(6):2523\u201338.","journal-title":"Transl Lung Cancer Res"},{"key":"7764_CR57","doi-asserted-by":"publisher","first-page":"215903","DOI":"10.1016\/j.canlet.2022.215903","volume":"549","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Kiang KM, Li N, Liu J, Zhang P, Jin L, et al. Folate enzyme MTHFD2 links one-carbon metabolism to unfolded protein response in glioblastoma. Cancer Lett. 2022;549:215903.","journal-title":"Cancer Lett"},{"key":"7764_CR58","doi-asserted-by":"publisher","first-page":"6361","DOI":"10.2147\/OTT.S210800","volume":"12","author":"Y Wei","year":"2019","unstructured":"Wei Y, Liu P, Li Q, Du J, Chen Y, Wang Y, et al. The effect of MTHFD2 on the proliferation and migration of colorectal cancer cell lines. Onco Targets Ther. 2019;12:6361\u201370.","journal-title":"Onco Targets Ther"},{"issue":"11","key":"7764_CR59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41389-020-00281-z","volume":"9","author":"D Tong","year":"2020","unstructured":"Tong D, Zhang J, Wang X, Li Q, Liu L, Lu A, et al. MiR-22, regulated by MeCP2, suppresses gastric cancer cell proliferation by inducing a deficiency in endogenous S-adenosylmethionine. Oncogenesis. 2020;9(11):99.","journal-title":"Oncogenesis"},{"issue":"1","key":"7764_CR60","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13048-022-00954-w","volume":"15","author":"X Cui","year":"2022","unstructured":"Cui X, Su H, Yang J, Wu X, Huo K, Jing X, et al. Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling. J Ovarian Res. 2022;15(1):23.","journal-title":"J Ovarian Res"},{"issue":"1","key":"7764_CR61","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41420-022-01098-y","volume":"8","author":"J Mo","year":"2022","unstructured":"Mo J, Gao Z, Zheng L, Yan M, Xue M, Xu J, et al. Targeting mitochondrial one-carbon enzyme MTHFD2 together with pemetrexed confers therapeutic advantages in lung adenocarcinoma. Cell Death Discov. 2022;8(1):307.","journal-title":"Cell Death Discov"},{"issue":"3","key":"7764_CR62","first-page":"1203","volume":"23","author":"SM Li","year":"2019","unstructured":"Li SM, Zhao YQ, Hao YL, Liang YY. Upregulation of miR-504-3p is associated with favorable prognosis of acute myeloid leukemia and May serve as a tumor suppressor by targeting MTHFD2. Eur Rev Med Pharmacol Sci. 2019;23(3):1203\u201313.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"7764_CR63","doi-asserted-by":"publisher","first-page":"e0299353","DOI":"10.1371\/journal.pone.0299353","volume":"19","author":"RVN Silva","year":"2024","unstructured":"Silva RVN, Berzotti LA, Laia MG, Araujo LS, Silva CA, Ribeiro KB, et al. Implications of MTHFD2 expression in renal cell carcinoma aggressiveness. PLoS ONE. 2024;19(2):e0299353.","journal-title":"PLoS ONE"},{"issue":"6","key":"7764_CR64","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1158\/0008-5472.CAN-24-0050","volume":"85","author":"J Liu","year":"2025","unstructured":"Liu J, Huang G, Lin H, Yang R, Zhan W, Luo C, et al. MTHFD2 enhances cMYC O-GlcNAcylation to promote Sunitinib resistance in renal cell carcinoma. Cancer Res. 2025;85(6):1113\u201329.","journal-title":"Cancer Res"},{"issue":"7","key":"7764_CR65","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1084\/jem.20151574","volume":"213","author":"Y Pikman","year":"2016","unstructured":"Pikman Y, Puissant A, Alexe G, Furman A, Chen LM, Frumm SM, et al. Targeting MTHFD2 in acute myeloid leukemia. J Exp Med. 2016;213(7):1285\u2013306.","journal-title":"J Exp Med"},{"issue":"15","key":"7764_CR66","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1158\/0008-5472.CAN-20-3956","volume":"81","author":"N Pallmann","year":"2021","unstructured":"Pallmann N, Deng K, Livgard M, Tesikova M, Jin Y, Frengen NS, et al. Stress-Mediated reprogramming of prostate cancer One-Carbon cycle drives disease progression. Cancer Res. 2021;81(15):4066\u201378.","journal-title":"Cancer Res"},{"key":"7764_CR67","doi-asserted-by":"crossref","unstructured":"Zhang F, Wang D, Li J, Su Y, Liu S, Lei QY, et al. Deacetylation of MTHFD2 by SIRT4 senses stress signal to inhibit cancer cell growth by remodeling folate metabolism. J Mol Cell Biol. 2022;14(4).","DOI":"10.1093\/jmcb\/mjac020"},{"issue":"8","key":"7764_CR68","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41419-020-02825-y","volume":"11","author":"X Wan","year":"2020","unstructured":"Wan X, Wang C, Huang Z, Zhou D, Xiang S, Qi Q, et al. Cisplatin inhibits SIRT3-deacetylation MTHFD2 to disturb cellular redox balance in colorectal cancer cell. Cell Death Dis. 2020;11(8):649.","journal-title":"Cell Death Dis"},{"issue":"8","key":"7764_CR69","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.dld.2016.04.015","volume":"48","author":"X Liu","year":"2016","unstructured":"Liu X, Huang Y, Jiang C, Ou H, Guo B, Liao H, et al. Methylenetetrahydrofolate dehydrogenase 2 overexpression is associated with tumor aggressiveness and poor prognosis in hepatocellular carcinoma. Dig Liver Dis. 2016;48(8):953\u201360.","journal-title":"Dig Liver Dis"},{"issue":"14","key":"7764_CR70","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1038\/s41388-018-0589-1","volume":"38","author":"T Nishimura","year":"2019","unstructured":"Nishimura T, Nakata A, Chen X, Nishi K, Meguro-Horike M, Sasaki S, et al. Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2. Oncogene. 2019;38(14):2464\u201381.","journal-title":"Oncogene"},{"issue":"6274","key":"7764_CR71","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1126\/science.aad0489","volume":"351","author":"I Ben-Sahra","year":"2016","unstructured":"Ben-Sahra I, Hoxhaj G, Ricoult SJH, Asara JM, Manning BD. mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle. Science. 2016;351(6274):728\u201333.","journal-title":"Science"},{"issue":"11","key":"7764_CR72","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/s41556-022-01002-x","volume":"24","author":"KC Kao","year":"2022","unstructured":"Kao KC, Vilbois S, Tsai CH, Ho PC. Metabolic communication in the tumour-immune microenvironment. Nat Cell Biol. 2022;24(11):1574\u201383.","journal-title":"Nat Cell Biol"},{"key":"7764_CR73","doi-asserted-by":"crossref","unstructured":"Deng X, Liu X, Hu B, Liu J, Fu B, Zhang W. Upregulation of MTHFD2 is associated with PD\u2013L1 activation in bladder cancer via the PI3K\/AKT pathway. Int J Mol Med. 2023;51(2).","DOI":"10.3892\/ijmm.2022.5217"},{"issue":"18","key":"7764_CR74","doi-asserted-by":"publisher","first-page":"17930","DOI":"10.18632\/aging.103471","volume":"12","author":"CH Chan","year":"2020","unstructured":"Chan CH, Wu CY, Dubey NK, Wei HJ, Lu JH, Mao S, et al. Modulating redox homeostasis and cellular reprogramming through inhibited methylenetetrahydrofolate dehydrogenase 2 enzymatic activities in lung cancer. Aging. 2020;12(18):17930\u201347.","journal-title":"Aging"},{"issue":"9","key":"7764_CR75","first-page":"2179","volume":"18","author":"P Marttila","year":"2024","unstructured":"Marttila P, Bonagas N, Chalkiadaki C, Stigsdotter H, Schelzig K, Shen J, et al. The one-carbon metabolic enzyme MTHFD2 promotes resection and homologous recombination after ionizing radiation. Mol Oncol. 2024;18(9):2179\u201395.","journal-title":"Mol Oncol"},{"issue":"1","key":"7764_CR76","doi-asserted-by":"publisher","first-page":"2345455","DOI":"10.1080\/13510002.2024.2345455","volume":"29","author":"HY Mo","year":"2024","unstructured":"Mo HY, Wang RB, Ma MY, Zhang Y, Li XY, Wen WR, et al. MTHFD2-mediated redox homeostasis promotes gastric cancer progression under hypoxic conditions. Redox Rep. 2024;29(1):2345455.","journal-title":"Redox Rep"},{"key":"7764_CR77","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbrc.2022.05.007","volume":"614","author":"S Wu","year":"2022","unstructured":"Wu S, Cai W, Shi Z, Ming X, Yang X, Zhou Y, et al. Knockdown of MTHFD2 inhibits proliferation and migration of nasopharyngeal carcinoma cells through the ERK signaling pathway. Biochem Biophys Res Commun. 2022;614:47\u201355.","journal-title":"Biochem Biophys Res Commun"},{"issue":"34","key":"7764_CR78","doi-asserted-by":"publisher","first-page":"6211","DOI":"10.1038\/s41388-019-0869-4","volume":"38","author":"NH Green","year":"2019","unstructured":"Green NH, Galvan DL, Badal SS, Chang BH, LeBleu VS, Long J, et al. MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinoma. Oncogene. 2019;38(34):6211\u201325.","journal-title":"Oncogene"},{"issue":"1","key":"7764_CR79","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41420-023-01398-x","volume":"9","author":"A Cappello","year":"2023","unstructured":"Cappello A, Zuccotti A, Mancini M, Tosetti G, Fania L, Ricci F, et al. Serine and one-carbon metabolism sustain non-melanoma skin cancer progression. Cell Death Discov. 2023;9(1):102.","journal-title":"Cell Death Discov"},{"key":"7764_CR80","doi-asserted-by":"publisher","first-page":"110579","DOI":"10.1016\/j.exer.2025.110579","volume":"260","author":"C Yao","year":"2025","unstructured":"Yao C, Chen T, Chen Y, Wu W, Li Y, Zhang Y, et al. MTHFD2 drives retinoblastoma progression via Notch signaling activation: implications for targeted pediatric ocular cancer therapy. Exp Eye Res. 2025;260:110579.","journal-title":"Exp Eye Res"},{"issue":"2","key":"7764_CR81","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1111\/jcmm.14844","volume":"24","author":"C Yu","year":"2020","unstructured":"Yu C, Yang L, Cai M, Zhou F, Xiao S, Li Y, et al. Down-regulation of MTHFD2 inhibits NSCLC progression by suppressing cycle-related genes. J Cell Mol Med. 2020;24(2):1568\u201377.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"7764_CR82","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41420-025-02498-6","volume":"11","author":"M Jia","year":"2025","unstructured":"Jia M, Fu Z, Ye C, Xu W, Liu J, Wu C, et al. Targeting MTHFD2 alters metabolic homeostasis and synergizes with bortezomib to inhibit multiple myeloma. Cell Death Discov. 2025;11(1):201.","journal-title":"Cell Death Discov"},{"issue":"11","key":"7764_CR83","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/s41419-019-2033-z","volume":"10","author":"CHY Cheung","year":"2019","unstructured":"Cheung CHY, Hsu CL, Tsuei CY, Kuo TT, Huang CT, Hsu WM, et al. Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy. Cell Death Dis. 2019;10(11):786.","journal-title":"Cell Death Dis"},{"issue":"4","key":"7764_CR84","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4048\/jbc.2016.19.4.349","volume":"19","author":"XB Zhao","year":"2016","unstructured":"Zhao XB, Ren GS. LncRNA Taurine-Upregulated gene 1 promotes cell proliferation by inhibiting MicroRNA-9 in MCF-7 cells. J Breast Cancer. 2016;19(4):349\u201357.","journal-title":"J Breast Cancer"},{"issue":"1","key":"7764_CR85","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12885-022-10433-6","volume":"23","author":"S Tange","year":"2023","unstructured":"Tange S, Hirano T, Idogawa M, Hirata E, Imoto I, Tokino T. MYEOV overexpression induced by demethylation of its promoter contributes to pancreatic cancer progression via activation of the folate cycle\/c-Myc\/mTORC1 pathway. BMC Cancer. 2023;23(1):85.","journal-title":"BMC Cancer"},{"key":"7764_CR86","doi-asserted-by":"crossref","unstructured":"Zhou H, Gong H, Zeng X, Zeng C, Liu D, Liu J, et al. MTHFD2 promotes esophageal squamous cell carcinoma progression via m6A modification\u2013mediated upregulation and modulation of the PEBP1\u2013RAF1 interaction. Int J Mol Med. 2025;55(5).","DOI":"10.3892\/ijmm.2025.5509"},{"issue":"8","key":"7764_CR87","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.7150\/ijms.81962","volume":"20","author":"S Wu","year":"2023","unstructured":"Wu S, Cai W, Li Y, Tan W, Yuan Y, Zhou Z, et al. SNHG3\/hsa-miR-455-5p Axis-mediated high expression of MTHFD2 correlates with tumor immune infiltration and endometrial carcinoma progression. Int J Med Sci. 2023;20(8):1097\u2013113.","journal-title":"Int J Med Sci"},{"issue":"1","key":"7764_CR88","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/s41467-024-45366-0","volume":"15","author":"SE Lee","year":"2024","unstructured":"Lee SE, Park S, Yi S, Choi NR, Lim MA, Chang JW, et al. Unraveling the role of the mitochondrial one-carbon pathway in undifferentiated thyroid cancer by multi-omics analyses. Nat Commun. 2024;15(1):1163.","journal-title":"Nat Commun"},{"issue":"8","key":"7764_CR89","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1161\/CIRCULATIONAHA.125.073691","volume":"152","author":"X Sun","year":"2025","unstructured":"Sun X, Wu J, He T, Yao M, Qin L, Weng C, et al. Mitochondrial One-Carbon metabolism drives CD34-Lineage cells to differentiate into T follicular helper cells to form tertiary lymphoid organs in transplant arteriosclerosis. Circulation. 2025;152(8):537\u201354.","journal-title":"Circulation"},{"key":"7764_CR90","doi-asserted-by":"publisher","first-page":"1414301","DOI":"10.3389\/fimmu.2024.1414301","volume":"15","author":"Y Wu","year":"2024","unstructured":"Wu Y, Hu H, Wang T, Guo W, Zhao S, Wei R. Characterizing mitochondrial features in osteoarthritis through integrative multi-omics and machine learning analysis. Front Immunol. 2024;15:1414301.","journal-title":"Front Immunol"},{"issue":"22","key":"7764_CR91","doi-asserted-by":"publisher","first-page":"10204","DOI":"10.1021\/acs.jmedchem.9b01113","volume":"62","author":"J Kawai","year":"2019","unstructured":"Kawai J, Toki T, Ota M, Inoue H, Takata Y, Asahi T, et al. Discovery of a Potent, Selective, and orally available MTHFD2 inhibitor (DS18561882) with in vivo antitumor activity. J Med Chem. 2019;62(22):10204\u201320.","journal-title":"J Med Chem"},{"issue":"1","key":"7764_CR92","doi-asserted-by":"publisher","first-page":"13","DOI":"10.15252\/emmm.201707993","volume":"10","author":"J Nikkanen","year":"2018","unstructured":"Nikkanen J, Landoni JC, Balboa D, Haugas M, Partanen J, Paetau A, et al. A complex genomic locus drives MtDNA replicase POLG expression to its disease-related nervous system regions. EMBO Mol Med. 2018;10(1):13\u201321.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"7764_CR93","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12916-025-03945-y","volume":"23","author":"Y Li","year":"2025","unstructured":"Li Y, Cai M, Qin Y, Dai X, Liang L, Li Z, et al. MTHFD2 promotes osteoclastogenesis and bone loss in rheumatoid arthritis by enhancing CKMT1-mediated oxidative phosphorylation. BMC Med. 2025;23(1):124.","journal-title":"BMC Med"},{"issue":"2","key":"7764_CR94","doi-asserted-by":"publisher","first-page":"2369342","DOI":"10.1080\/0886022X.2024.2369342","volume":"46","author":"W Hu","year":"2024","unstructured":"Hu W. EP300-mediated H3 acetylation elevates MTHFD2 expression to reduce mitochondrial dysfunction in lipopolysaccharide-induced tubular epithelial cells. Ren Fail. 2024;46(2):2369342.","journal-title":"Ren Fail"},{"issue":"2","key":"7764_CR95","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s13577-025-01189-9","volume":"38","author":"S Sun","year":"2025","unstructured":"Sun S, Han B, Ren G, Fan L, Sun J, Li H, et al. MTHFD2 stabilizes LOX expression through RNA methylation modification to promote sepsis-induced acute kidney injury progression. Hum Cell. 2025;38(2):62.","journal-title":"Hum Cell"},{"issue":"3","key":"7764_CR96","doi-asserted-by":"publisher","first-page":"106094","DOI":"10.1016\/j.isci.2023.106094","volume":"26","author":"G Callegaro","year":"2023","unstructured":"Callegaro G, Schimming JP, Pinero Gonzalez J, Kunnen SJ, Wijaya L, Trairatphisan P, et al. Identifying multiscale translational safety biomarkers using a network-based systems approach. iScience. 2023;26(3):106094.","journal-title":"iScience"},{"issue":"13","key":"7764_CR97","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1167\/iovs.61.13.4","volume":"61","author":"K Kamel","year":"2020","unstructured":"Kamel K, O\u2019Brien CJ, Zhdanov AV, Papkovsky DB, Clark AF, Stamer WD, et al. Reduced oxidative phosphorylation and increased Glycolysis in human glaucoma lamina cribrosa cells. Invest Ophthalmol Vis Sci. 2020;61(13):4.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7764_CR98","doi-asserted-by":"publisher","first-page":"103060","DOI":"10.1016\/j.redox.2024.103060","volume":"70","author":"P Amadio","year":"2024","unstructured":"Amadio P, Sandrini L, Zara M, Barbieri SS, Ieraci A. NADPH-oxidases as potential Pharmacological targets for thrombosis and depression comorbidity. Redox Biol. 2024;70:103060.","journal-title":"Redox Biol"},{"issue":"1","key":"7764_CR99","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12885-024-11890-x","volume":"24","author":"XW Yu","year":"2024","unstructured":"Yu XW, She PW, Chen FC, Chen YY, Zhou S, Wang XM, et al. Metabolic subtypes and immune landscapes in esophageal squamous cell carcinoma: prognostic implications and potential for personalized therapies. BMC Cancer. 2024;24(1):230.","journal-title":"BMC Cancer"},{"issue":"1","key":"7764_CR100","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3892\/or.2016.5264","volume":"37","author":"M Miyo","year":"2017","unstructured":"Miyo M, Konno M, Colvin H, Nishida N, Koseki J, Kawamoto K, et al. The importance of mitochondrial folate enzymes in human colorectal cancer. Oncol Rep. 2017;37(1):417\u201325.","journal-title":"Oncol Rep"},{"key":"7764_CR101","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.actbio.2021.11.042","volume":"140","author":"S Yang","year":"2022","unstructured":"Yang S, Wong KH, Hua P, He C, Yu H, Shao D, et al. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy. Acta Biomater. 2022;140:492\u2013505.","journal-title":"Acta Biomater"},{"issue":"4","key":"7764_CR102","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s00432-024-05731-4","volume":"150","author":"L Wang","year":"2024","unstructured":"Wang L, He Y, Bai Y, Zhang S, Pang B, Chen A, et al. Construction and validation of a folate metabolism-related gene signature for predicting prognosis in HNSCC. J Cancer Res Clin Oncol. 2024;150(4):198.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"7764_CR103","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1139\/bcb-2022-0291","volume":"101","author":"M Huang","year":"2023","unstructured":"Huang M, Xue J, Chen Z, Zhou X, Chen M, Sun J, et al. MTHFD2 suppresses glioblastoma progression via the Inhibition of ERK1\/2 phosphorylation. Biochem Cell Biol. 2023;101(1):112\u201324.","journal-title":"Biochem Cell Biol"},{"key":"7764_CR104","doi-asserted-by":"publisher","first-page":"7527996","DOI":"10.1155\/2022\/7527996","volume":"2022","author":"Y Gao","year":"2022","unstructured":"Gao Y, Feng L, Zhang L, Geng J, Zhang E. ATF4\/MYC regulates MTHFD2 to promote NSCLC progression by mediating redox homeostasis. Dis Markers. 2022;2022:7527996.","journal-title":"Dis Markers"},{"key":"7764_CR105","doi-asserted-by":"crossref","unstructured":"Zhang Y, Stovall DB, Wan M, Zhang Q, Chou JW, Li D, et al. SOX7 target genes and their contribution to its tumor suppressive function. Int J Mol Sci. 2018;19(5).","DOI":"10.3390\/ijms19051451"},{"issue":"1","key":"7764_CR106","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1186\/s12885-022-09606-0","volume":"22","author":"L Zhu","year":"2022","unstructured":"Zhu L, Liu X, Zhang W, Hu H, Wang Q, Xu K. MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder. BMC Cancer. 2022;22(1):556.","journal-title":"BMC Cancer"},{"key":"7764_CR107","doi-asserted-by":"publisher","first-page":"1245629","DOI":"10.3389\/fendo.2023.1245629","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Liu N, Zhou X, Zhao L, Wei W, Hu J, et al. Constructing a prognostic model for head and neck squamous cell carcinoma based on glucose metabolism related genes. Front Endocrinol (Lausanne). 2023;14:1245629.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7764_CR108","doi-asserted-by":"publisher","first-page":"1326509","DOI":"10.3389\/fimmu.2023.1326509","volume":"14","author":"X Shi","year":"2023","unstructured":"Shi X, Peng X, Chen Y, Shi Z, Yue C, Zuo L, et al. Overexpression of MTHFD2 represents an inflamed tumor microenvironment and precisely predicts the molecular subtype and immunotherapy response of bladder cancer. Front Immunol. 2023;14:1326509.","journal-title":"Front Immunol"},{"issue":"1","key":"7764_CR109","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1038\/s41467-021-22173-5","volume":"12","author":"M Shang","year":"2021","unstructured":"Shang M, Yang H, Yang R, Chen T, Fu Y, Li Y, et al. The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation. Nat Commun. 2021;12(1):1940.","journal-title":"Nat Commun"},{"issue":"5","key":"7764_CR110","doi-asserted-by":"publisher","first-page":"112481","DOI":"10.1016\/j.celrep.2023.112481","volume":"42","author":"M Shang","year":"2023","unstructured":"Shang M, Ni L, Shan X, Cui Y, Hu P, Ji Z, et al. MTHFD2 reprograms macrophage polarization by inhibiting PTEN. Cell Rep. 2023;42(5):112481.","journal-title":"Cell Rep"},{"issue":"8033","key":"7764_CR111","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41586-024-07693-6","volume":"634","author":"JR Lavillegrand","year":"2024","unstructured":"Lavillegrand JR, Al-Rifai R, Thietart S, Guyon T, Vandestienne M, Cohen R, et al. Alternating high-fat diet enhances atherosclerosis by neutrophil reprogramming. Nature. 2024;634(8033):447\u201356.","journal-title":"Nature"},{"issue":"21","key":"7764_CR112","doi-asserted-by":"publisher","first-page":"e2418467122","DOI":"10.1073\/pnas.2418467122","volume":"122","author":"TY Luk","year":"2025","unstructured":"Luk TY, Yim LY, Zhou R, Mo Y, Huang H, Zhao M, et al. BRD9 functions as an HIV-1 latency regulatory factor. Proc Natl Acad Sci U S A. 2025;122(21):e2418467122.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"7764_CR113","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/toxres\/tfad077","volume":"12","author":"J An","year":"2023","unstructured":"An J, Yi Y, Jiang J, Yao W, Ren G, Shang Y. Metabolic disturbance and transcriptomic changes induced by Methyl triclosan in human hepatocyte L02 cells. Toxicol Res (Camb). 2023;12(5):863\u201372.","journal-title":"Toxicol Res (Camb)"},{"issue":"3","key":"7764_CR114","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2303951","volume":"389","author":"SP Bhatt","year":"2023","unstructured":"Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Cole J, Bafadhel M, et al. Dupilumab for COPD with type 2 inflammation indicated by eosinophil counts. N Engl J Med. 2023;389(3):205\u201314.","journal-title":"N Engl J Med"},{"issue":"7","key":"7764_CR115","doi-asserted-by":"publisher","first-page":"e2407134","DOI":"10.1002\/advs.202407134","volume":"12","author":"W Sun","year":"2025","unstructured":"Sun W, Zhou S, Peng L, Wang W, Liu Y, Wang T, et al. Fatty acid Oxidation-Glycolysis metabolic transition affects ECM homeostasis in Silica-Induced pulmonary fibrosis. Adv Sci (Weinh). 2025;12(7):e2407134.","journal-title":"Adv Sci (Weinh)"},{"issue":"4","key":"7764_CR116","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.cmet.2020.02.017","volume":"31","author":"L Yang","year":"2020","unstructured":"Yang L, Garcia Canaveras JC, Chen Z, Wang L, Liang L, Jang C, et al. Serine catabolism feeds NADH when respiration is impaired. Cell Metab. 2020;31(4):809\u201321. e6.","journal-title":"Cell Metab"},{"issue":"7690","key":"7764_CR117","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nature25460","volume":"554","author":"RJ Morscher","year":"2018","unstructured":"Morscher RJ, Ducker GS, Li SH, Mayer JA, Gitai Z, Sperl W, et al. Mitochondrial translation requires folate-dependent tRNA methylation. Nature. 2018;554(7690):128\u201332.","journal-title":"Nature"},{"key":"7764_CR118","doi-asserted-by":"publisher","first-page":"10723","DOI":"10.2147\/JIR.S533116","volume":"18","author":"Z Yang","year":"2025","unstructured":"Yang Z, Dong Y, Shang Y, Li H, Ren W, Li S, et al. Host Circulating Immunometabolism-Associated biomarkers for early diagnosis of active tuberculosis: Multi-Omics screening with experimental validation. J Inflamm Res. 2025;18:10723\u201340.","journal-title":"J Inflamm Res"},{"issue":"7951","key":"7764_CR119","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1038\/d41586-023-00651-8","volume":"615","author":"C Schmidt","year":"2023","unstructured":"Schmidt C. Confronting Racial and ethnic disparities in diabetic kidney disease. Nature. 2023;615(7951):S8\u20139.","journal-title":"Nature"},{"issue":"11","key":"7764_CR120","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.healun.2023.07.009","volume":"42","author":"Y Li","year":"2023","unstructured":"Li Y, Chen Z, Cui J, Yu J, Niu Y, Ran S, et al. MTHFD2 ablation in T cells protects against heart transplant rejection by perturbing IRF4\/PD-1 pathway through the metabolic-epigenetic nexus. J Heart Lung Transpl. 2023;42(11):1608\u201320.","journal-title":"J Heart Lung Transpl"},{"issue":"7","key":"7764_CR121","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1021\/acs.jcim.4c02318","volume":"65","author":"C Wu","year":"2025","unstructured":"Wu C, Ren Y, Li Y, Cui Y, Zhang L, Zhang P, et al. Identification and experimental validation of NETosis-Mediated abdominal aortic aneurysm gene signature using Multi-omics, machine Learning, and Mendelian randomization. J Chem Inf Model. 2025;65(7):3771\u201388.","journal-title":"J Chem Inf Model"},{"issue":"8","key":"7764_CR122","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.4049\/jimmunol.2300209","volume":"212","author":"Y Cui","year":"2024","unstructured":"Cui Y, Li Z, Ni L, Yu S, Shan X, Hu P, et al. Induction of MTHFD2 in macrophages inhibits reactive oxygen Species-mediated NF-kappaB activation and protects against inflammatory responses. J Immunol. 2024;212(8):1345\u201356.","journal-title":"J Immunol"},{"issue":"10","key":"7764_CR123","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.stem.2024.07.009","volume":"31","author":"C Du","year":"2024","unstructured":"Du C, Liu C, Yu K, Zhang S, Fu Z, Chen X, et al. Mitochondrial Serine catabolism safeguards maintenance of the hematopoietic stem cell pool in homeostasis and injury. Cell Stem Cell. 2024;31(10):1484\u2013500. e9.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"7764_CR124","first-page":"100939","volume":"19","author":"X Wang","year":"2024","unstructured":"Wang X, Ren X, Lin X, Li Q, Zhang Y, Deng J, et al. Recent progress of ferroptosis in cancers and drug discovery. Asian J Pharm Sci. 2024;19(4):100939.","journal-title":"Asian J Pharm Sci"},{"issue":"1","key":"7764_CR125","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41467-017-01671-5","volume":"8","author":"C Fu","year":"2017","unstructured":"Fu C, Sikandar A, Donner J, Zaburannyi N, Herrmann J, Reck M, et al. The natural product Carolacton inhibits folate-dependent C1 metabolism by targeting FolD\/MTHFD. Nat Commun. 2017;8(1):1529.","journal-title":"Nat Commun"},{"issue":"6","key":"7764_CR126","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1021\/acsmedchemlett.9b00069","volume":"10","author":"J Kawai","year":"2019","unstructured":"Kawai J, Ota M, Ohki H, Toki T, Suzuki M, Shimada T, et al. Structure-Based design and synthesis of an Isozyme-Selective MTHFD2 inhibitor with a tricyclic coumarin scaffold. ACS Med Chem Lett. 2019;10(6):893\u20138.","journal-title":"ACS Med Chem Lett"},{"key":"7764_CR127","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbrc.2021.11.001","volume":"584","author":"J Lee","year":"2021","unstructured":"Lee J, Chen X, Wang Y, Nishimura T, Li M, Ishikawa S, et al. A novel oral inhibitor for one-carbon metabolism and checkpoint kinase 1 inhibitor as a rational combination treatment for breast cancer. Biochem Biophys Res Commun. 2021;584:7\u201314.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"7764_CR128","doi-asserted-by":"publisher","first-page":"e01021","DOI":"10.1016\/j.heliyon.2018.e01021","volume":"4","author":"A Asai","year":"2018","unstructured":"Asai A, Koseki J, Konno M, Nishimura T, Gotoh N, Satoh T, et al. Drug discovery of anticancer drugs targeting methylenetetrahydrofolate dehydrogenase 2. Heliyon. 2018;4(12):e01021.","journal-title":"Heliyon"},{"issue":"2","key":"7764_CR129","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s43018-022-00331-y","volume":"3","author":"N Bonagas","year":"2022","unstructured":"Bonagas N, Gustafsson NMS, Henriksson M, Marttila P, Gustafsson R, Wiita E, et al. Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress. Nat Cancer. 2022;3(2):156\u201372.","journal-title":"Nat Cancer"},{"issue":"15","key":"7764_CR130","doi-asserted-by":"publisher","first-page":"11288","DOI":"10.1021\/acs.jmedchem.1c00663","volume":"64","author":"LC Lee","year":"2021","unstructured":"Lee LC, Peng YH, Chang HH, Hsu T, Lu CT, Huang CH, et al. Xanthine derivatives reveal an allosteric binding site in methylenetetrahydrofolate dehydrogenase 2 (MTHFD2). J Med Chem. 2021;64(15):11288\u2013301.","journal-title":"J Med Chem"},{"key":"7764_CR131","doi-asserted-by":"publisher","first-page":"117703","DOI":"10.1016\/j.ejmech.2025.117703","volume":"292","author":"Y Hu","year":"2025","unstructured":"Hu Y, He X, Li S, Zhang T, Liao J, Xu N, et al. Hit to lead optimization of isopentenyl Chalcones as novel MTHFD2 inhibitors for cancer treatment: design, synthesis, in-vitro, in-vivo and in-silico studies. Eur J Med Chem. 2025;292:117703.","journal-title":"Eur J Med Chem"},{"issue":"3","key":"7764_CR132","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1007\/s12013-025-01732-3","volume":"83","author":"A Abuelsamen","year":"2025","unstructured":"Abuelsamen A, Alhawarri MB, Al-Thiabat MG, Makhadmeh GN, AlZoubi T, Alrimawi BH, et al. Theranostic potential of Copper-64 ATSM targeting MTHFD2: an in Silico perspective on Hypoxia-Selective imaging and therapy. Cell Biochem Biophys. 2025;83(3):3503\u201321.","journal-title":"Cell Biochem Biophys"},{"issue":"1","key":"7764_CR133","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s12013-024-01474-8","volume":"83","author":"MB Alhawarri","year":"2025","unstructured":"Alhawarri MB. Exploring the anticancer potential of furanpydone A: A computational study on its Inhibition of MTHFD2 across diverse cancer cell lines. Cell Biochem Biophys. 2025;83(1):437\u201354.","journal-title":"Cell Biochem Biophys"},{"key":"7764_CR134","doi-asserted-by":"crossref","unstructured":"Sevimoglu T, Caliskaner ZO. Dissecting the dual drug candidates against glioblastoma and oligodendroglioma through integrated transcriptome analysis and virtual screening. Cell Biochem Biophys. 2025;83(4):4869-4884.","DOI":"10.1007\/s12013-025-01808-0"},{"issue":"9","key":"7764_CR135","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1016\/j.cmet.2024.07.010","volume":"36","author":"ARP Verkerke","year":"2024","unstructured":"Verkerke ARP, Shi X, Li M, Higuchi Y, Yamamuro T, Katoh D, et al. SLC25A48 controls mitochondrial choline import and metabolism. Cell Metab. 2024;36(9):2156\u201366. e9.","journal-title":"Cell Metab"},{"issue":"21","key":"7764_CR136","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1002\/1878-0261.13227","volume":"16","author":"T Helleday","year":"2022","unstructured":"Helleday T, Rudd SG. Targeting the DNA damage response and repair in cancer through nucleotide metabolism. Mol Oncol. 2022;16(21):3792\u2013810.","journal-title":"Mol Oncol"},{"issue":"4","key":"7764_CR137","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1158\/0008-5472.CAN-16-1476","volume":"77","author":"R Gustafsson","year":"2017","unstructured":"Gustafsson R, Jemth AS, Gustafsson NM, Farnegardh K, Loseva O, Wiita E, et al. Crystal structure of the emerging cancer target MTHFD2 in complex with a Substrate-Based inhibitor. Cancer Res. 2017;77(4):937\u201348.","journal-title":"Cancer Res"},{"key":"7764_CR138","doi-asserted-by":"crossref","unstructured":"Binmujlli MA. Radiological and molecular analysis of radioiodinated anastrozole and epirubicin as innovative radiopharmaceuticals targeting methylenetetrahydrofolate dehydrogenase 2 in solid tumors. Pharmaceutics. 2024;16(5).","DOI":"10.3390\/pharmaceutics16050616"},{"issue":"7929","key":"7764_CR139","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/s41586-022-05168-0","volume":"609","author":"NJ Wright","year":"2022","unstructured":"Wright NJ, Fedor JG, Zhang H, Jeong P, Suo Y, Yoo J, et al. Methotrexate recognition by the human reduced folate carrier SLC19A1. Nature. 2022;609(7929):1056\u201362.","journal-title":"Nature"},{"issue":"1","key":"7764_CR140","doi-asserted-by":"publisher","first-page":"9529","DOI":"10.1038\/s41467-024-51847-z","volume":"15","author":"N Pardo-Lorente","year":"2024","unstructured":"Pardo-Lorente N, Gkanogiannis A, Cozzuto L, Ganez Zapater A, Espinar L, Ghose R, et al. Nuclear localization of MTHFD2 is required for correct mitosis progression. Nat Commun. 2024;15(1):9529.","journal-title":"Nat Commun"},{"issue":"2","key":"7764_CR141","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/biolre\/ioae175","volume":"112","author":"JR Sangalli","year":"2025","unstructured":"Sangalli JR, Nociti RP, Chiaratti MR, Bridi A, Botigelli RC, Ambrizi DR, et al. Beta-hydroxybutyrate alters bovine preimplantation embryo development through transcriptional and epigenetic Mechanismsdagger. Biol Reprod. 2025;112(2):253\u201372.","journal-title":"Biol Reprod"},{"key":"7764_CR142","doi-asserted-by":"publisher","first-page":"111808","DOI":"10.1016\/j.cellsig.2025.111808","volume":"132","author":"Q Xu","year":"2025","unstructured":"Xu Q, Zhou Y, Wu M, Wu S, Yu J, Xu Y, et al. MTHFD2: A metabolic checkpoint altering trophoblast invasion and migration by remodeling folate-nucleotide metabolism in recurrent spontaneous abortion. Cell Signal. 2025;132:111808.","journal-title":"Cell Signal"},{"key":"7764_CR143","doi-asserted-by":"publisher","first-page":"103379","DOI":"10.1016\/j.redox.2024.103379","volume":"77","author":"H Yan","year":"2024","unstructured":"Yan H, Yin Y, Zhou Y, Li Z, Li Y, Ren L, et al. Regulation of cardiovascular diseases by histone deacetylases and NADPH oxidases. Redox Biol. 2024;77:103379.","journal-title":"Redox Biol"},{"issue":"11","key":"7764_CR144","doi-asserted-by":"publisher","first-page":"eadj6406","DOI":"10.1126\/sciadv.adj6406","volume":"10","author":"A Singh","year":"2024","unstructured":"Singh A, Ottavi S, Krieger I, Planck K, Perkowski A, Kaneko T, et al. Redirecting raltitrexed from cancer cell thymidylate synthase to Mycobacterium tuberculosis phosphopantetheinyl transferase. Sci Adv. 2024;10(11):eadj6406.","journal-title":"Sci Adv"},{"issue":"2","key":"7764_CR145","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2165\/00003088-198713020-00004","volume":"13","author":"WA Mahon","year":"1987","unstructured":"Mahon WA, Leeder JS, Brill-Edwards MM, Correia J, MacLeod SM. Comparative bioavailability study of three sustained release Quinidine formulations. Clin Pharmacokinet. 1987;13(2):118\u201324.","journal-title":"Clin Pharmacokinet"},{"key":"7764_CR146","doi-asserted-by":"crossref","unstructured":"Tochowicz A, Dalziel S, Eidam O, O\u2019Connell JD 3rd, Griner S, Finer-Moore JS, et al. Development and binding mode assessment of N-[4-[2-propyn-1-yl[(6S)-4,6,7,8-tetrahydro-2-(hydroxymethyl)-4-oxo-3H-cyclopenta[g]quinazolin-6-yl]amino]benzoyl]-l-gamma-glutamyl-D-glutamic acid (BGC 945), a novel thymidylate synthase inhibitor that targets tumor cells. J Med Chem. 2013;56(13):5446\u201355.","DOI":"10.1021\/jm400490e"},{"issue":"2","key":"7764_CR147","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.ygyno.2013.07.080","volume":"131","author":"CL Walters","year":"2013","unstructured":"Walters CL, Arend RC, Armstrong DK, Naumann RW, Alvarez RD. Folate and folate receptor alpha antagonists mechanism of action in ovarian cancer. Gynecol Oncol. 2013;131(2):493\u20138.","journal-title":"Gynecol Oncol"},{"issue":"Suppl 1","key":"7764_CR148","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1007\/s00280-003-0625-9","volume":"52","author":"E Chu","year":"2003","unstructured":"Chu E, Callender MA, Farrell MP, Schmitz JC. Thymidylate synthase inhibitors as anticancer agents: from bench to bedside. Cancer Chemother Pharmacol. 2003;52(Suppl 1):S80\u20139.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"7764_CR149","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","volume":"15","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang H, Merkher Y, Chen L, Liu N, Leonov S, et al. Recent advances in therapeutic strategies for triple-negative breast cancer. J Hematol Oncol. 2022;15(1):121.","journal-title":"J Hematol Oncol"},{"key":"7764_CR150","doi-asserted-by":"crossref","unstructured":"Li Y, Elakad O, Yao S, von Hammerstein-Equord A, Hinterthaner M, Danner BC, et al. Regulation and therapeutic targeting of MTHFD2 and EZH2 in KRAS-mutated human pulmonary adenocarcinoma. Metabolites. 2022;12(7).","DOI":"10.3390\/metabo12070652"},{"key":"7764_CR151","doi-asserted-by":"publisher","first-page":"e073980","DOI":"10.1136\/bmj-2022-073980","volume":"383","author":"EF Morand","year":"2023","unstructured":"Morand EF, Fernandez-Ruiz R, Blazer A, Niewold TB. Advances in the management of systemic lupus erythematosus. BMJ. 2023;383:e073980.","journal-title":"BMJ"},{"issue":"2","key":"7764_CR152","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41419-024-06490-3","volume":"15","author":"J Guan","year":"2024","unstructured":"Guan J, Li M, Wang Y, Zhang Y, Que Y, Lu S, et al. MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma. Cell Death Dis. 2024;15(2):124.","journal-title":"Cell Death Dis"},{"issue":"1","key":"7764_CR153","doi-asserted-by":"publisher","first-page":"21073","DOI":"10.1038\/s41598-024-71879-1","volume":"14","author":"V Jha","year":"2024","unstructured":"Jha V, Eriksson LA. Selectivity analysis of diaminopyrimidine-based inhibitors of MTHFD1, MTHFD2 and MTHFD2L. Sci Rep. 2024;14(1):21073.","journal-title":"Sci Rep"},{"issue":"18","key":"7764_CR154","doi-asserted-by":"publisher","first-page":"e202200274","DOI":"10.1002\/cmdc.202200274","volume":"17","author":"ER Scaletti","year":"2022","unstructured":"Scaletti ER, Gustafsson Westergren R, Andersson Y, Wiita E, Henriksson M, Homan EJ, et al. The first structure of human MTHFD2L and its implications for the development of Isoform-Selective inhibitors. Chem Med Chem. 2022;17(18):e202200274.","journal-title":"ChemMedChem"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07764-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07764-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07764-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T01:03:13Z","timestamp":1777942993000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07764-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":154,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7764"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07764-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have consented to publish this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"625"}}